Global Single-Use Equipment for Biopharmaceutical Market Size By Type (Single-use Bioreactors (SUBs), Membrane Adsorbers), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to...

lobal Single-Use Equipment for Biopharmaceutical Market Report Description

The Global Single-Use Equipment for Biopharmaceutical Market was valued at USD 7.8 billion in 2023 and is projected to reach USD 19.4 billion by 2031, growing at a CAGR of 12.1% during the forecast period (2023–2031).

The rising adoption of single-use technologies in biopharmaceutical manufacturing is driven by the growing demand for flexible production systems, cost-effectiveness, and reduced contamination risks. Single-use equipment eliminates the need for complex cleaning procedures, enhances process efficiency, and reduces turnaround time, making it a preferred solution for biologics and vaccine production.

The market’s growth is further accelerated by the rapid expansion of biologics, monoclonal antibodies, cell and gene therapies, and the need for scalable manufacturing processes. Increasing investments in biopharmaceutical R&D, coupled with a strong focus on sustainability and reduced water and energy consumption, are contributing to the widespread adoption of single-use systems.

Key Market Drivers

✅ Growing Demand for Biologics and Personalized Medicines

The increasing prevalence of chronic diseases, cancer, and rare disorders has fueled the demand for biologics, cell therapies, and gene therapies. Single-use equipment offers flexibility and scalability required for such specialized manufacturing processes.

✅ Cost-Effectiveness and Operational Efficiency

Single-use systems reduce cleaning validation, sterilization requirements, and associated labor costs. This cost efficiency makes them highly attractive for both small-scale clinical manufacturing and large-scale commercial production.

✅ Reduced Risk of Cross-Contamination

Unlike traditional stainless-steel systems, single-use equipment significantly lowers the risk of product cross-contamination, ensuring higher safety and compliance with stringent regulatory guidelines.

✅ Rapidly Expanding Biopharmaceutical Outsourcing

CMOs and CDMOs are increasingly adopting single-use systems due to their versatility, faster changeovers, and ability to meet multi-product manufacturing requirements.

Market Restraints

❌ High Material and Procurement Costs

While single-use systems lower operational costs, the high recurring expenses of consumables and materials can be a restraint for some manufacturers.

❌ Concerns over Leachables and Extractables

Potential contamination from plastic components in single-use systems remains a regulatory and quality concern, requiring extensive validation.

❌ Waste Management Challenges

The large-scale disposal of single-use plastics raises environmental concerns, leading to a need for improved recycling solutions.

Market Opportunities

🌟 Adoption in Emerging Biopharma Hubs

Rapid biopharma infrastructure development in Asia-Pacific and Latin America presents significant growth opportunities.

🌟 Integration of Smart & Automated Single-Use Technologies

Advancements in sensors, automation, and process analytics are creating opportunities for next-generation single-use systems that improve process control and efficiency.

🌟 Growth in Cell and Gene Therapy Manufacturing

The increasing demand for small-batch, high-value therapies is accelerating the adoption of flexible single-use technologies.

Market by System Type Insights

Single-Use Bioreactors dominated the market in 2023, accounting for the largest revenue share. These systems are widely used in upstream processing for monoclonal antibodies and vaccines due to their scalability and efficiency.

Single-Use Mixers are expected to register the fastest growth, driven by their critical role in downstream processing, formulation, and buffer preparation.

Market by End-Use Insights

Biopharmaceutical Companies were the leading end-users in 2023, driven by the high demand for biologics and continuous manufacturing.

Contract Manufacturing Organizations (CMOs/CDMOs) are projected to grow at the highest CAGR, as outsourcing of biologics manufacturing becomes more prevalent.

Market by Regional Insights

North America dominated the market in 2023, supported by strong biologics production, advanced biomanufacturing infrastructure, and high adoption of innovative technologies.

Europe holds a significant share due to the presence of major biopharma companies and favorable regulatory frameworks.

Asia-Pacific is expected to witness the fastest growth, fueled by rapid expansion of biomanufacturing facilities in China, India, and South Korea, along with government initiatives to boost biologics production.

Competitive Scenario

Key players in the Global Single-Use Equipment for Biopharmaceutical Market include:

Sartorius AG

Thermo Fisher Scientific

Danaher Corporation (Cytiva, Pall Corporation)

Merck KGaA

Saint-Gobain

Eppendorf SE

Avantor, Inc.

Corning Incorporated

PBS Biotech

Entegris, Inc.

These companies focus on strategic acquisitions, technological innovations, and partnerships to strengthen their market presence.

Key Recent Developments:

2023: Sartorius launched an advanced single-use bioreactor platform with enhanced sensor integration for improved process monitoring.

2023: Thermo Fisher expanded its single-use manufacturing capacity in Europe to meet the growing demand for biologics production.

2024: Danaher (Cytiva) acquired a biotech technology firm to enhance its single-use upstream processing portfolio.

Scope of Work – Global Single-Use Equipment for Biopharmaceutical Market

FAQs

1. What is the current market size of the Global Single-Use Equipment for Biopharmaceutical Market?

The market was valued at USD 7.8 billion in 2023.

2. What is the major growth driver of the Global Single-Use Equipment for Biopharmaceutical Market?

The major driver is the increasing demand for biologics, vaccines, and flexible manufacturing solutions that reduce contamination risks and operational costs.

3. Which is the largest region during the forecast period in the Global Single-Use Equipment for Biopharmaceutical Market?

North America holds the largest market share, driven by strong biologics production and advanced biomanufacturing infrastructure.

4. Which segment accounted for the largest market share in the Global Single-Use Equipment for Biopharmaceutical Market?

The Single-Use Bioreactors segment dominated the market in 2023.

5. Who are the key market players in the Global Single-Use Equipment for Biopharmaceutical Market?

Key players include Sartorius AG, Thermo Fisher Scientific, Danaher (Cytiva), Merck KGaA, and Saint-Gobain.

Would you like me to generate a visually formatted PDF report for this market description, with charts and an infographic-style design?